Phase I clinical trial of LGD-4033, a novel selective androgen receptor modulator (SARM)

被引：0
|
作者：
Meglasson, Martin D. [1 ]
Kapil, Ram [1 ]
Leibowitz, Mark T. [2 ]
Peterkin, Joanna J. [3 ]
Chen, Yanling [1 ]
Lee, Kyoung-Jin [1 ]
Lee, Yong-Hee [1 ]
Vajda, Eric G. [1 ]
机构：
[1] Ligand Pharmaceut Inc, La Jolla, CA 92037 USA
[2] CEDRA Clin Res LLC, San Antonio, TX USA
[3] Joanna J Peterkin Consulting LLC, Rancho Santa Fe, CA USA
来源：
ENDOCRINE JOURNAL | 2010年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S542 / S542
页数：1
相关论文
共 50 条
  • [41] Initial clinical trial of a selective retinoid X receptor ligand, LGD1069
    Miller, VA
    Benedetti, FM
    Rigas, JR
    Verret, AL
    Pfister, DG
    Straus, D
    Kris, MG
    Crisp, M
    Heyman, R
    Loewen, GR
    Truglia, JA
    Warrell, RP
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) : 790 - 795
  • [42] RESULTS FROM TWO PHASE 3 RANDOMIZED TRIALS OF ENOBOSARM, SELECTIVE ANDROGEN RECEPTOR MODULATOR (SARM), FOR THE PREVENTION AND TREATMENT OF MUSCLE WASTING IN NSCLC.
    Crawford, Jeffrey
    Prado, Carla M. M.
    Hancock, Michael L.
    Johnston, Mary A.
    Dalton, James T.
    Steiner, Mitchell S.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1199 - S1199
  • [43] Differential effects of 5α-dihydrotesterosterone (DHT) and a novel selective androgen receptor modulator (SARM) on prostate and bone in intact and orchidectomized (ORX) male rats.
    Ke, HZ
    Crawford, DT
    Qi, H
    Simmons, HA
    Li, M
    Brown, TA
    Thompson, DD
    Wang, XN
    Salter, ED
    O'Malley, JP
    Salatto, CT
    Hill, RJ
    Lefker, BA
    Cameron, KO
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S406 - S407
  • [44] Nonsteroidal, tissue selective androgen receptor modulator (SARM), enobosarm, reduces growth of androgen receptor-positive breast cancer in patient-derived preclinical models
    Narayanan, R.
    Ponnusamy, S.
    Fan, M.
    Yang, C. H.
    Grimes, B. L.
    Fleming, M. D.
    Pritchard, E. F.
    Berry, M. P.
    Oswaks, R. M.
    Fine, R. E.
    Loiseau, J-C
    Schwartzberg, L. S.
    Pfeffer, L. M.
    CANCER RESEARCH, 2017, 77
  • [45] A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2-Metastatic Breast Cancer
    LoRusso, Patricia
    Hamilton, Erika
    Ma, Cynthia
    Vidula, Neelima
    Bagley, Rebecca G.
    Troy, Steven
    Annett, Miriam
    Yu, Ziyang
    Conlan, Maureen G.
    Weise, Amy
    CLINICAL BREAST CANCER, 2022, 22 (01) : 67 - 77
  • [46] A selective androgen receptor modulator SARM-2f activates androgen receptor, increases lean body mass, and suppresses blood lipid levels in cynomolgus monkeys
    Morimoto, Megumi
    Yamaoka, Masuo
    Hara, Takahito
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2020, 8 (01):
  • [47] Pharmacological characterization of AC-262536, a novel selective androgen receptor modulator
    Piu, Fabrice
    Gardell, Luis R.
    Son, Thomas
    Schlienger, Nathalie
    Lund, Birgitte W.
    Schiffer, Hans H.
    Vanover, Kim E.
    Davis, Robert E.
    Olsson, Roger
    Bradley, Stefania Risso
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2008, 109 (1-2): : 129 - 137
  • [48] A novel, nonsteroidal selective androgen receptor modulator (SARM) increases periosteal bone formation and inhibits trabecular bone turnover in aged intact and orchidectomized male rats
    Ke, HZ
    Crawford, DT
    Qi, H
    Simmons, HA
    Li, M
    Brown, TA
    Salter, ED
    O'Malley, JP
    Salatto, CT
    Lefker, BA
    Gant, TG
    Hill, RJ
    Wang, XN
    Thompson, DD
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S56 - S56
  • [49] A phase II clinical trial of pembrolizumab and selective androgen receptor modulator GTx-024 in patients with advanced androgen receptor-positive triple-negative breast cancer.
    Lee-Bitar, Jin Sun
    Frankel, Paul Henry
    Yost, Susan Elaine
    Synold, Timothy W.
    Martinez, Norma
    Tang, Aileen
    Schmolze, Dan
    Apple, Sophia
    Hurria, Arti
    Waisman, James Ross
    Somlo, George
    Patel, Niki Tank
    Sedrak, Mina S.
    Mortimer, Joanne E.
    Yuan, Yuan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [50] AN ORAL NONSTEROIDAL SELECTIVE ANDROGEN RECEPTOR MODULATOR, TEI-SARM2, PREVENTS DISUSE MUSCLE ATROPHY AND CANCER CACHEXIA
    Kanou, M.
    Horie, K.
    Nakamura, K.
    Makino, A.
    Sugiyama, H.
    Yamana, K.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S186 - S186
12345